378 related articles for article (PubMed ID: 28716801)
1. Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.
Swoboda PP; McDiarmid AK; Erhayiem B; Ripley DP; Dobson LE; Garg P; Musa TA; Witte KK; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28716801
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Elajami TK; Alfaddagh A; Lakshminarayan D; Soliman M; Chandnani M; Welty FK
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710178
[TBL] [Abstract][Full Text] [Related]
3. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
[TBL] [Abstract][Full Text] [Related]
4. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
Jhund PS; Claggett BL; Voors AA; Zile MR; Packer M; Pieske BM; Kraigher-Krainer E; Shah AM; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
Circ Heart Fail; 2014 Nov; 7(6):953-9. PubMed ID: 25277997
[TBL] [Abstract][Full Text] [Related]
5. The independent association of myocardial extracellular volume and myocardial blood flow with cardiac diastolic function in patients with type 2 diabetes: a prospective cross-sectional cohort study.
Bojer AS; Sørensen MH; Madsen SH; Broadbent DA; Plein S; Gæde P; Madsen PL
Cardiovasc Diabetol; 2023 Mar; 22(1):78. PubMed ID: 37004049
[TBL] [Abstract][Full Text] [Related]
6. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes.
Swoboda PP; Erhayiem B; Kan R; McDiarmid AK; Garg P; Musa TA; Dobson LE; Witte KK; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S
Cardiovasc Diabetol; 2018 Mar; 17(1):35. PubMed ID: 29506523
[TBL] [Abstract][Full Text] [Related]
8. Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction.
Pastormerlo LE; Mammini C; Giannoni A; Valleggi A; Prontera C; Gabutti A; Poletti R; Padeletti L; Emdin M; Passino C
J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):423-30. PubMed ID: 25083720
[TBL] [Abstract][Full Text] [Related]
9. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
[TBL] [Abstract][Full Text] [Related]
10. Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus.
Yokota S; Tanaka H; Mochizuki Y; Soga F; Yamashita K; Tanaka Y; Shono A; Suzuki M; Sumimoto K; Mukai J; Suto M; Takada H; Matsumoto K; Hirota Y; Ogawa W; Hirata KI
Cardiovasc Diabetol; 2019 Dec; 18(1):166. PubMed ID: 31805945
[TBL] [Abstract][Full Text] [Related]
11. Novel Index of Maladaptive Myocardial Remodeling in Hypertension.
Goh VJ; Le TT; Bryant J; Wong JI; Su B; Lee CH; Pua CJ; Sim CPY; Ang B; Aw TC; Cook SA; Chin CWL
Circ Cardiovasc Imaging; 2017 Sep; 10(9):e006840. PubMed ID: 28847911
[TBL] [Abstract][Full Text] [Related]
12. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
[TBL] [Abstract][Full Text] [Related]
13. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.
Lampropoulou IT; Stangou M; Papagianni A; Didangelos T; Iliadis F; Efstratiadis G
J Diabetes Res; 2014; 2014():394206. PubMed ID: 25587544
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
16. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
[TBL] [Abstract][Full Text] [Related]
17. Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.
Hellemons ME; Denig P; de Zeeuw D; Voorham J; Lambers Heerspink HJ
Nephrol Dial Transplant; 2013 Mar; 28(3):706-15. PubMed ID: 23262433
[TBL] [Abstract][Full Text] [Related]
18. Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
Docherty KF; Campbell RT; Brooksbank KJM; Dreisbach JG; Forsyth P; Godeseth RL; Hopkins T; Jackson AM; Lee MMY; McConnachie A; Roditi G; Squire IB; Stanley B; Welsh P; Jhund PS; Petrie MC; McMurray JJV
Circulation; 2021 Jul; 144(3):199-209. PubMed ID: 33983794
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Kristensen SL; Mogensen UM; Jhund PS; Petrie MC; Preiss D; Win S; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Gottdiener JS; Carson PE; McMurray JJ
Circulation; 2017 Feb; 135(8):724-735. PubMed ID: 28052977
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
